Development of Processed Meat Products and New Products to Meet Market Needs
First written in FY2016. 20 of 34 entries say "Restated". Latest entry: 2026-09-29.
22 other companies' latest entry also says "Advanced".
- FY2026AdvancedAnnual report
「In addition, we have begun developing products using the horizontal form-fill-seal packaging machine newly installed at the Motomiya Plant. During the current fiscal year, we are conducting verification through the test production and sale of multiple products. Going forward, we will also consider expanding our national-brand products while working to improve our processing technologies and product capabilities.」
Product development has advanced to the verification stage through the test production and sale of multiple products using the new equipment, with the expansion of national-brand products also under consideration. Research and development expenses amounted to ¥97 million. - 2026-05-28AdvancedOther Disclosures
「With this in mind, we redefined the domestic branded pork “Kodawari Pork” from the consumer’s perspective and launched a new brand, “Genki no Baton.”」
The existing domestic branded pork has been redefined from the consumer’s perspective, and the launch of a new brand conveying health-related value, together with its in-store presentation, has been specified. - FY2025AdvancedAnnual report
「A hamburger branding team comprising the Sales and Manufacturing divisions was formed, and the formulation was revised to reduce additives as much as possible and make better use of the ingredients.」
For processed-food and new-product development, the company formed a hamburger branding team from the Sales and Manufacturing divisions and made specific improvements to the formulation by reducing additives and making better use of the ingredients. R&D expenses totaled ¥94 million. - FY2025-H1RestatedAnnual report
「Total research and development expenses for the current interim consolidated accounting period were ¥49 million. There was no material change in the status of the group’s R&D activities during the current interim consolidated accounting period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥49 million for the current interim consolidated accounting period. - FY2024RestatedAnnual report
「Our Manufacturing Headquarters is strengthening basic research into products combining surimi and organ meat, which are cost-competitive raw materials. Demand for lower-priced products is also increasing, and we are strengthening development of hamburgers with a competitive advantage over other companies.」
In response to market conditions, the company continued research into products using surimi and organ meat, development of lower-priced hamburgers, improvements and new-product development at ローマイヤ, and strengthened development of the “Zero Meat Series.” R&D expenses were ¥86 million. - FY2024-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥17 million. There was no material change in the status of the group’s R&D activities during the first quarter of the current consolidated cumulative period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥17 million for the first quarter of the current cumulative period. - FY2023AdvancedAnnual report
「The Development Division is strengthening its basic research and researching alternative secondary ingredients to replace those with unstable prices and supply. It is also introducing new equipment, such as small molding machines, and working to establish hamburgers with a competitive advantage through differentiation in texture and improvements in quality, including juiciness.」
For hamburger development, the company added specific measures including research into alternative secondary ingredients, the introduction of small molding machines, and improvements in texture and juiciness. R&D expenses totaled ¥76 million. - FY2023-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥60 million. There was no material change in the status of the group’s R&D activities during the third quarter of the current consolidated cumulative period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥60 million for the third quarter of the current cumulative period. - FY2023-Q2RestatedAnnual report
「Total research and development expenses for the second quarter of the current consolidated cumulative period were ¥39 million. There was no material change in the status of the group’s R&D activities during the second quarter of the current consolidated cumulative period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥39 million for the second quarter of the current cumulative period. - FY2023-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥18 million. There was no material change in the status of the group’s R&D activities during the first quarter of the current consolidated cumulative period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥18 million for the first quarter of the current cumulative period. - FY2022AdvancedAnnual report
「We will continue to strengthen development of the “Zero Meat Series,” which uses soybeans instead of any meat to achieve a meat-like texture, taste, and aroma and has attracted attention in recent years as a meat-alternative product. The group’s total R&D expenses for the consolidated fiscal year were ¥79 million, consisting primarily of expenditures on R&D activities in the meat-related business.」
The company continued strengthening development of the “Zero Meat Series” as a meat-alternative product and recorded R&D expenses of ¥79 million. - FY2022-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥58 million. There was no material change in the status of the group’s R&D activities during the third quarter of the current consolidated cumulative period.」
The company stated that there had been no material change in its R&D activities and disclosed R&D expenses of ¥58 million for the third quarter of the current consolidated cumulative period. - FY2022-Q2RestatedAnnual report
「Total R&D expenses for the cumulative second quarter of the current consolidated fiscal year were ¥38 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥38 million for the second quarter of the current consolidated cumulative period. It stated that there had been no material change in the status of its activities. - FY2022-Q1AdvancedAnnual report
「As a new initiative, we entered into a business alliance agreement with Fuji Sogo Foods Co., Ltd. in July this year. Through this alliance, we will accelerate the joint development of high-value-added products, including meal kits, by drawing on both companies’ technologies, capabilities, and expertise, and will work to make the products developed by both companies available not only for home consumption but also for the foodservice and ready-to-eat markets.」
The business alliance with Fuji Sogo Foods will accelerate the joint development of value-added products such as meal kits, with plans to expand beyond home consumption to the foodservice and ready-to-eat markets. - FY2021AdvancedAnnual report
「In particular, development of the “Zero Meat Hamburger,” which uses soybeans instead of any meat to achieve a meat-like texture, taste, and aroma, is continuing in anticipation of future growth in the meat-alternative market.」
In addition to conventional processed-food and new-product development, the company explicitly stated that it would continue developing the soy-based “Zero Meat Hamburger” in anticipation of future growth in the meat-alternative market. R&D expenses were ¥86 million. - FY2021-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥74 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥74 million for the third quarter of the current consolidated cumulative period. - FY2021-Q2RestatedAnnual report
「Total research and development expenses for the second quarter of the current consolidated fiscal year were ¥57 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥57 million for the second quarter of the current consolidated cumulative period. - FY2021-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated fiscal year were ¥21 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥21 million for the first quarter of the current consolidated cumulative period. - FY2020-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥81 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥81 million for the third quarter of the current consolidated cumulative period. - FY2020-Q2RestatedAnnual report
「Total research and development expenses for the second quarter of the current consolidated cumulative period were ¥48 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥48 million for the second quarter of the current consolidated cumulative period. - FY2020-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥20 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥20 million for the first quarter of the current consolidated cumulative period. - FY2019AdvancedAnnual report
「Starzen Foods Co., Ltd. promoted the development and commercialization of microwave-ready products centered on hamburgers to address the prepared-foods market, where demand is rising as nuclear families and dual-income households become more prevalent.」
Microwave-ready products for the prepared-foods market were commercialized, while ローマイヤ advanced the development and commercialization of new products and technologies, including sausages. R&D expenses totaled ¥86 million. - FY2019-Q1AdvancedAnnual report
「We jointly developed the original-brand pork product “小麦のブラン三元豚” with Orimer, a leading Canadian pork packer. In addition, to address the prepared-foods market, where demand is rising as nuclear families and dual-income households become more prevalent, we developed the microwave-ready product “麦黒牛ハンバーグ” and began sales in mid-June.」
In addition to jointly developing an original-brand pork product with Orimer, the company developed a microwave-ready product for the prepared-foods market and began sales in mid-June. - FY2018AdvancedAnnual report
「As part of these efforts, Starzen Foods has developed and commercialized a diverse range of processed meat products, including hamburgers, while ローマイヤ㈱ has worked to develop new products and technologies, including roast beef and roast pork, with the aim of enhancing its brand image.」
Starzen Foods and ローマイヤ continued developing processed foods, new products, and new technologies, and R&D expenses for the consolidated fiscal year totaled ¥63 million. - FY2018-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥48 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥48 million for the third quarter of the current consolidated cumulative period. - FY2018-Q2RestatedAnnual report
「Total research and development expenses for the second quarter of the current consolidated cumulative period were ¥31 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥31 million for the second quarter of the current consolidated cumulative period. - FY2018-Q1RestatedAnnual report
「Total R&D expenses for the cumulative first quarter of the current consolidated fiscal year were ¥13 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥13 million for the first quarter of the current consolidated cumulative period. - FY2017-Q3RestatedAnnual report
「Total research and development expenses for the third quarter of the current consolidated cumulative period were ¥31 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥31 million for the third quarter of the current consolidated cumulative period. - FY2017-Q2RestatedAnnual report
「Total R&D expenses for the six months ended Q2 were ¥17 million.」
The company continued its R&D activities and disclosed R&D expenses of ¥17 million for the second quarter of the current consolidated cumulative period. - FY2017-Q1RestatedAnnual report
「Total research and development expenses for the first quarter of the current consolidated cumulative period were ¥9 million.」
The company disclosed continued R&D activities and R&D expenses of ¥9 million, but did not provide details of new products or technologies. - FY2016First statedAnnual report
「Our group has worked to develop products based on the core concept of enabling customers to enjoy safe products with confidence and in good taste, in response to changes in the market and customer needs. As part of these efforts, the Food Manufacturing Headquarters of Starzen Company Limited has developed and commercialized a diverse range of processed meat products, including hamburgers. ローマイヤ㈱ has been working to develop new products and technologies, including roast beef and roast pork, with the aim of enhancing its brand image. As a result, total research and development expenses for the consolidated fiscal year were ¥34 million, comprising ¥30 million in the meat-related business and ¥3 million in other businesses.」
The company described specific activities including the development and commercialization of processed foods and the development of new products and technologies, and also disclosed R&D expenses for the fiscal year.